Skip to main content
Clinical Trials/ISRCTN00283877
ISRCTN00283877
Completed
N/A

A multicentre study to determine the efficacy and patient acceptability of scalp cooling in the prevention of docetaxel-induced hair loss

eiden University Medical Centre (LUMC) (The Netherlands)0 sites260 target enrollmentSeptember 12, 2005

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
eiden University Medical Centre (LUMC) (The Netherlands)
Enrollment
260
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 12, 2005
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
eiden University Medical Centre (LUMC) (The Netherlands)

Eligibility Criteria

Inclusion Criteria

  • 1\. Intravenous administered docetaxel regimes
  • 2\. Age 18 years or more
  • 3\. Written informed consent

Exclusion Criteria

  • 1\. Boldness before the start of the study
  • 2\. Haematological malignancies with generalised haematogenic metastases (e.g. lymphoma, leukaemia and multiple myeloma) and if in those conditions chemotherapy is given with a curative intent
  • 3\. Clinical signs of scalp metastases
  • 4\. Cold sensitivity
  • 5\. Cold agglutinin disease
  • 6\. Cryoglobulinaemia
  • 7\. Cryofibrinogenaemia

Outcomes

Primary Outcomes

Not specified

Similar Trials